Invesco Ltd. Has $220,000 Stake in Aehr Test Systems $AEHR

Key Points

• Invesco Ltd. increased its stake in Aehr Test Systems by 88.8% in Q1, owning 30,226 shares valued at $220,000.
• Insider selling included VP Alistair N. Sporck, who sold 3,000 shares, and Director Laura Oliphant, who sold 5,000 shares, resulting in significant decreases in their ownership percentages.
• Aehr Test Systems reported an EPS of ($0.01) for the latest quarter, slightly beating estimates, and had revenue of $14.10 million, which fell short of analyst expectations.

Invesco Ltd. raised its stake in Aehr Test Systems (NASDAQ:AEHR - Free Report) by 88.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 30,226 shares of the semiconductor company's stock after acquiring an additional 14,219 shares during the period. Invesco Ltd. owned about 0.10% of Aehr Test Systems worth $220,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Two Sigma Investments LP grew its position in Aehr Test Systems by 12.2% in the fourth quarter. Two Sigma Investments LP now owns 48,624 shares of the semiconductor company's stock valued at $809,000 after acquiring an additional 5,276 shares during the period. Raymond James Financial Inc. acquired a new stake in Aehr Test Systems during the 4th quarter valued at $272,000. Dimensional Fund Advisors LP increased its holdings in Aehr Test Systems by 1.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 137,241 shares of the semiconductor company's stock valued at $2,283,000 after purchasing an additional 2,365 shares in the last quarter. XTX Topco Ltd acquired a new stake in Aehr Test Systems during the 1st quarter valued at $267,000. Finally, Price T Rowe Associates Inc. MD increased its holdings in Aehr Test Systems by 23.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 24,716 shares of the semiconductor company's stock valued at $412,000 after purchasing an additional 4,772 shares in the last quarter. 69.69% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Aehr Test Systems

In other news, VP Alistair N. Sporck sold 3,000 shares of the firm's stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $14.13, for a total value of $42,390.00. Following the transaction, the vice president directly owned 30,808 shares in the company, valued at $435,317.04. This trade represents a 8.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Laura Oliphant sold 5,000 shares of the firm's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $21.50, for a total value of $107,500.00. Following the completion of the transaction, the director owned 7,665 shares in the company, valued at $164,797.50. This represents a 39.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 26,000 shares of company stock worth $506,830. Insiders own 6.20% of the company's stock.

Aehr Test Systems Price Performance

AEHR stock opened at $25.19 on Tuesday. The stock has a market capitalization of $753.68 million, a price-to-earnings ratio of -193.75 and a beta of 2.53. The business has a fifty day moving average price of $19.08 and a 200 day moving average price of $12.75. Aehr Test Systems has a fifty-two week low of $6.27 and a fifty-two week high of $27.51.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 8th. The semiconductor company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The firm had revenue of $14.10 million for the quarter, compared to analyst estimates of $14.83 million. Aehr Test Systems had a negative return on equity of 0.15% and a negative net margin of 6.63%. On average, equities analysts expect that Aehr Test Systems will post 0.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised Aehr Test Systems to a "sell" rating in a report on Tuesday, May 13th.

Aehr Test Systems Company Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.